CIVALLERO, Monica
 Distribuzione geografica
Continente #
NA - Nord America 3.334
EU - Europa 1.298
AS - Asia 1.174
SA - Sud America 185
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.035
Nazione #
US - Stati Uniti d'America 3.304
GB - Regno Unito 428
CN - Cina 400
SG - Singapore 346
IT - Italia 245
HK - Hong Kong 167
SE - Svezia 153
BR - Brasile 143
DE - Germania 119
RU - Federazione Russa 85
VN - Vietnam 85
UA - Ucraina 61
TR - Turchia 47
FI - Finlandia 40
FR - Francia 39
IE - Irlanda 27
BG - Bulgaria 24
ID - Indonesia 22
IN - India 22
KR - Corea 21
MA - Marocco 19
BE - Belgio 18
CA - Canada 18
JP - Giappone 18
AR - Argentina 15
NL - Olanda 15
ZA - Sudafrica 11
MX - Messico 10
MY - Malesia 7
AT - Austria 6
BD - Bangladesh 6
CL - Cile 6
EC - Ecuador 6
LT - Lituania 6
PE - Perù 6
PL - Polonia 6
CH - Svizzera 5
EG - Egitto 5
IQ - Iraq 5
ES - Italia 3
IR - Iran 3
LB - Libano 3
PK - Pakistan 3
PY - Paraguay 3
RO - Romania 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
CZ - Repubblica Ceca 2
IL - Israele 2
KW - Kuwait 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CD - Congo 1
CM - Camerun 1
CO - Colombia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.035
Città #
Ashburn 389
Fairfield 375
Santa Clara 335
Southend 304
Chandler 259
Woodbridge 236
Singapore 235
Hong Kong 166
Houston 161
Ann Arbor 130
Seattle 121
Cambridge 117
Nyköping 109
Wilmington 104
Jacksonville 83
Hefei 82
Dearborn 78
London 78
Beijing 64
Modena 57
New York 48
Los Angeles 43
The Dalles 43
San Diego 40
Chicago 34
Dublin 27
Ho Chi Minh City 27
Izmir 27
Frankfurt am Main 25
Princeton 25
Sofia 24
Moscow 23
Fremont 22
Munich 22
Hanoi 21
Helsinki 21
Seoul 21
Dallas 20
Jakarta 20
Shanghai 20
Eugene 19
Brussels 18
Council Bluffs 17
Salt Lake City 17
Casablanca 16
Cologno Monzese 16
Milan 16
São Paulo 14
Norwalk 12
Tokyo 11
Buffalo 10
Des Moines 10
Pisa 10
San Giuliano Milanese 9
Bremen 8
Columbus 8
Falls Church 8
Lviv 8
Brusaporto 7
Johannesburg 7
Montreal 7
Nuremberg 7
Parma 7
Redondo Beach 7
Amsterdam 6
Atlanta 6
Boston 6
Changsha 6
Dong Ket 6
Guangzhou 6
Orem 6
Phoenix 6
Redwood City 6
San Francisco 6
Boardman 5
Brasília 5
Brooklyn 5
Contagem 5
Latina 5
Ottawa 5
Rome 5
San Jose 5
Tampa 5
Warsaw 5
Belo Horizonte 4
Bologna 4
Campinas 4
Chongqing 4
Da Nang 4
Lappeenranta 4
Nanjing 4
Nova Milanese 4
Poplar 4
Rio de Janeiro 4
Stockholm 4
Toronto 4
Wuhan 4
Arezzo 3
Ascoli Piceno 3
Buenos Aires 3
Totale 4.476
Nome #
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 356
Activity of BKM120 and BEZ235 against lymphoma cells 329
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 317
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 311
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 306
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 288
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 257
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 256
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 252
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 250
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 243
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 241
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 238
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 225
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 217
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 215
Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression 206
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 190
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 179
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project 173
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project 155
COVID-related disruption in mammographic screening: a year later. 151
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply 149
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 145
The Value and relevance of T-cell lymphoma registries 120
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project 110
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network 107
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project 93
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 5
Totale 6.084
Categoria #
all - tutte 24.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 45 40 79 31 83 51 38
2021/2022555 36 29 63 29 9 64 36 22 44 46 107 70
2022/2023648 74 114 44 66 43 95 7 57 88 7 25 28
2023/2024421 18 24 18 50 82 34 43 47 5 17 48 35
2024/20251.230 50 11 36 103 233 179 96 68 120 43 102 189
2025/20261.151 176 84 165 227 323 176 0 0 0 0 0 0
Totale 6.084